Dong Mei Shi
Overview
Explore the profile of Dong Mei Shi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang Z, Ma X, Shao Q, Li Q, Wang Y, Liang J, et al.
Rev Cardiovasc Med
. 2024 Jul;
23(7):230.
PMID: 39076896
Background: Homeostasis of thyroid hormones has significant effects on the cardiovascular system. The aim of this study was to investigate the association between free triiodothyronine (FT3) and adverse cardiovascular events...
2.
Gao F, Li Y, Ma X, Wang Z, Shi D, Zhou Y
Front Cardiovasc Med
. 2022 May;
9:907662.
PMID: 35600486
Background: Proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors have been documented with significantly reduction in LDL cholesterol levels and cardiovascular events. However, evidence regarding the impact of PCSK9 inhibitors...
3.
Yang L, Wang Z, Shi D, Chai M, Zhang L, Cheng W, et al.
Angiology
. 2019 Nov;
71(3):281-287.
PMID: 31777276
We sought to compare the effects of smoking on clinical outcomes in women and men with coronary artery disease undergoing percutaneous coronary intervention (PCI). We prospectively followed up 10 369...
4.
Zhu L, Shi D, Dai Q, Cheng X, Yao W, Sun P, et al.
Oncotarget
. 2014 Jul;
5(14):5403-15.
PMID: 24980821
X-linked inhibitor of apoptosis (XIAP)-associated factor 1 (XAF1), a XIAP-binding protein, is a tumor suppressor gene. XAF1 was silent or expressed lowly in most human malignant tumors. However, the role...
5.
Wang Z, Hu W, Liu Y, Shi D, Cheng W, Guo Y, et al.
Can J Cardiol
. 2013 Dec;
30(1):96-101.
PMID: 24365194
Background: This small study has determined the effect of vitamin C on myocardial reperfusion in patients undergoing elective percutaneous coronary intervention (PCI). This study was to explore whether antioxidant vitamin...
6.
Wang Z, Guo M, Si T, Ming Jiang M, Liu S, Liu Y, et al.
Coron Artery Dis
. 2013 Aug;
24(7):589-95.
PMID: 23939299
Objective: The aim of this study was to investigate the impact of depression on the clinical outcomes of patients with coronary artery disease undergoing percutaneous coronary intervention (PCI). Methods: A...
7.
Wang Z, Harjai K, Shenoy C, Gao F, Shi D, Liu Y, et al.
Am J Kidney Dis
. 2013 Jun;
62(4):711-21.
PMID: 23773369
Background: Decreased estimated glomerular filtration rate (eGFR) is a strong predictor of both mortality and subsequent cardiac events after percutaneous coronary intervention. The safety and efficacy of drug-eluting (DESs) versus...
8.
Luo S, Zhou Y, Shi D, Ge H, Wang J, Liu R
Can J Cardiol
. 2013 Feb;
29(9):1084-9.
PMID: 23414904
Background: Myocardial necrosis occurs frequently in elective percutaneous coronary intervention (PCI) and is associated with subsequent major adverse cardiovascular events (MACEs). This study assessed the protective effect of remote ischemic...
9.
Wang Z, Zhao Y, Liu Y, Shi D, Gao F, Liu X, et al.
Coron Artery Dis
. 2012 Jul;
23(6):404-11.
PMID: 22828723
Objectives: To examine whether obesity has a similar effect on long-term prognosis between men and women undergoing a percutaneous coronary intervention (PCI). Methods: We separately examined 3926 men and 2157...
10.
Wang Z, Zhou Y, Zhao Y, Liu Y, Shi D, Liu X, et al.
Obesity (Silver Spring)
. 2011 Jul;
20(1):141-6.
PMID: 21720423
Obesity is a major risk factor for developing coronary artery disease. The impact of obesity on prognosis among those with established coronary disease is less clear. The objective of this...